115 related articles for article (PubMed ID: 9681935)
1. Effects of the GABAergic system on in vivo binding of [3H]N-methylspiperone.
Nakano T; Kobayashi K; Hosoi R; Wakahara S; Watanabe Y; Nishimura T; Inoue O
Neuropharmacology; 1998; 37(3):375-81. PubMed ID: 9681935
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo. Short communication.
Inoue O; Wakahara S; Kobayashi K; Gee A
J Neural Transm (Vienna); 1999; 106(2):131-7. PubMed ID: 10226933
[TBL] [Abstract][Full Text] [Related]
3. The effect of benzodiazepines on the binding of [3H]SCH 23390 in vivo.
Inoue O; Kobayashi K; Sakiyama Y; Suzuki T
Neuropharmacology; 1992 Feb; 31(2):115-21. PubMed ID: 1313156
[TBL] [Abstract][Full Text] [Related]
4. Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain.
Unterwald EM; Tsukada H; Kakiuchi T; Kosugi T; Nishiyama S; Kreek MJ
Brain Res; 1997 Nov; 775(1-2):183-8. PubMed ID: 9439841
[TBL] [Abstract][Full Text] [Related]
5. Swim stress alters in vivo binding of [3H]N-methylspiperone.
Inoue O; Tsukada H; Kobayashi K; Suhara T; Itoh T
Neuropharmacology; 1991 Oct; 30(10):1101-6. PubMed ID: 1684648
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
Frost JJ; Smith AC; Kuhar MJ; Dannals RF; Wagner HN
Life Sci; 1987 Mar; 40(10):987-95. PubMed ID: 3821368
[TBL] [Abstract][Full Text] [Related]
7. Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.
Tsukada H; Kreuter J; Maggos CE; Unterwald EM; Kakiuchi T; Nishiyama S; Futatsubashi M; Kreek MJ
J Neurosci; 1996 Dec; 16(23):7670-7. PubMed ID: 8922423
[TBL] [Abstract][Full Text] [Related]
8. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B
Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566
[TBL] [Abstract][Full Text] [Related]
9. In vivo binding of (3H)Ro 15-1788 in mice: comparison with the in vivo binding of (3H)flunitrazepam.
Potier MC; Prado de Carvalho L; Dodd RH; Brown CL; Rossier J
Life Sci; 1988; 43(16):1287-96. PubMed ID: 2845217
[TBL] [Abstract][Full Text] [Related]
10. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
11. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
Calon F; Goulet M; Blanchet PJ; Martel JC; Piercey MF; Bédard PJ; Di Paolo T
Brain Res; 1995 May; 680(1-2):43-52. PubMed ID: 7663983
[TBL] [Abstract][Full Text] [Related]
12. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
[TBL] [Abstract][Full Text] [Related]
13. Effects of cerebral ischemia on dopamine receptors in the gerbil striatum.
Araki T; Kato H; Shuto K; Fujiwara T; Kogure K; Itoyama Y
Eur J Pharmacol; 1996 Jun; 306(1-3):73-9. PubMed ID: 8813617
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
Panagopoulos NT; Matsokis NA; Valcana T
J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
[TBL] [Abstract][Full Text] [Related]
15. Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain.
Inoue O; Kobayashi K; Tsukada H; Itoh T; Langstrom B
J Neural Transm Gen Sect; 1991; 85(1):1-10. PubMed ID: 1678266
[TBL] [Abstract][Full Text] [Related]
16. Characterization of [3H]nemonapride binding to mouse brain dopamine D2 receptors assessed in vivo and ex vivo for metabolic modeling in PET studies.
Ishiwata K; Inami K; Sasaki T; Nozaki T; Senda M
J Neural Transm Gen Sect; 1994; 97(2):119-33. PubMed ID: 7873122
[TBL] [Abstract][Full Text] [Related]
17. Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone.
Inoue O; Kobayashi K; Hosoi R; Yamaguchi M; Gee A
J Neural Transm (Vienna); 1999; 106(11-12):1099-104. PubMed ID: 10651106
[TBL] [Abstract][Full Text] [Related]
18. Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences.
Harsing LG; Zigmond MJ
Neuroscience; 1997 Mar; 77(2):419-29. PubMed ID: 9472401
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels.
Möhler H; Burkard WP; Keller HH; Richards JG; Haefely W
J Neurochem; 1981 Sep; 37(3):714-22. PubMed ID: 6268754
[TBL] [Abstract][Full Text] [Related]
20. Effect of sabcomeline on muscarinic and dopamine receptor binding in intact mouse brain.
Hosoi R; Kobayashi K; Ishida J; Yamaguchi M; Inoue O
Ann Nucl Med; 2003 Apr; 17(2):123-30. PubMed ID: 12790361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
